Figure 7.

Progesterone metabolizing enzyme pathways and primary metabolites affected by altered gene expression in breast carcinoma tissue. (3αHP: 4-pregnen-3α-ol-20-one; 20αDHP: 4-pregnen-20α-ol-3-one; 5αP: 5α-pregnane-3,20-dione).

Lewis et al. BMC Cancer 2004 4:27   doi:10.1186/1471-2407-4-27
Download authors' original image